首页> 美国卫生研究院文献>Chimerism >Major and minor histocompatibility antigens to NIMA
【2h】

Major and minor histocompatibility antigens to NIMA

机译:NIMA的主要和次要组织相容性抗原

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The immunologic effects of developmental exposure to non-inherited maternal antigens (NIMA) are heterogeneous, either tolerogenic or immunogenic. The role of minor histocompatibility antigens (MiHA) in NIMA effects is unknown. We have recently reported that the NIMA effect can be classified into two distinct reactivities, low and high responder, to NIMA in utero and during nursing depending on the degree of maternal microchimerism (MMc) and Foxp3 expression of peripheral blood CD4+CD25+ cells after graft-versus-host disease (GVHD) induction. These reactivities were predictable before transplantation, using an MLR-ELISPOT (mixed lymphocyte reaction; enzyme-linked immunospot) assay by comparing the number of IFNγ-producing cells stimulated with NIMA. Moreover, this assay was also applicable in both major and minor NIMA-mismatched setting. These observations are clinically relevant and suggest that it is possible to predict the immunological tolerance to NIMA.
机译:发育性暴露于非遗传性母体抗原(NIMA)的免疫学作用是异源的,无论是耐受性的还是免疫性的。次要组织相容性抗原(MiHA)在NIMA效应中的作用尚不清楚。我们最近报道,根据母体微嵌合体(MMc)和外周血CD4 + <移植物抗宿主病(GVHD)诱导后的/ sup> CD25 + 细胞。通过MLR-ELISPOT(混合淋巴细胞反应;酶联免疫斑点)测定,可以比较移植后用NIMA刺激产生IFNγ的细胞数量,从而预测这些反应性。而且,该测定法也适用于主要和次要的NIMA不匹配的情况。这些观察结果在临床上是相关的,并暗示有可能预测对NIMA的免疫耐受性。

著录项

  • 期刊名称 Chimerism
  • 作者单位
  • 年(卷),期 2011(2),1
  • 年度 2011
  • 页码 23–24
  • 总页数 2
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号